Atlas Trials

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Clinical trial NCT01514149 · TERMINATED

Trial details

NCT number
NCT01514149
Sponsor
ConjuChem
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2011-09-01
Primary completion
2012-05-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.